Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B

0
105
bostonbased valo seriesmccoy wichita businessjournal

bostonbased valo seriesmccoy wichita businessjournal

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B  —  A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.
Keep visiting teckno.blog for the latest news and updates.
Daniel Harrison

Leave a reply